President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases.
The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.
"We're going to be able to make that drug available almost immediately," Trump said.
The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.
He also tempered the president's optimism about the still-untested solution.
"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."
New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.
"The therapies are something we could move on much faster potentially," Trump said.
He claimed the administration "slashed red tape" to develop new vaccines and therapies.
The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks.
"If we find that we need something, then we will do that," he said.
Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak.
The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.
"We continue our relentless effort to defeat the Chinese virus," Trump said.
President Joe Biden made his first public comments about his son Hunter Biden's plea deal with federal prosecutors on two misdemeanor tax charges. This follows several critical comments by Republicans, who blasted the agreement as a "sweetheart deal."
A federal judge struck down Arkansas' first-in-the-nation ban on gender-affirming care for children as unconstitutional Tuesday, the first ruling to overturn such a prohibition as a growing number of Republican-led states adopt similar restrictions.
Climate change is on trial in Montana. In a landmark case, 16 young people are suing the state over effects like smoke, heat, and drought. It's just the first in a series of cases intended to pressure lawmakers into taking action on the environment. Here with more is Cheddar News Senior Reporter Chloe Aiello.
President Joe Biden’s son Hunter will plead guilty to federal tax offenses and avoid prosecution on a separate gun charge in a deal with the Justice Department that likely spares him time behind bars.
A White House official said First lady Jill Biden is hosting a roundtable conversation on Tuesday that will bring together women who have been denied medical care since the overturning of Roe v. Wade last year.
Former president Donald Trump told Fox News' Bret Baier said on Monday that he did not show classified documents to anyone else after his term.
President Joe Biden will convene a group of technology leaders on Tuesday to debate artificial intelligence.
More than 1 million people have been dropped from Medicaid in the past couple of months as some states moved swiftly to halt healthcare coverage following the end of the coronavirus pandemic.
Thousands of Iraqis, many of whom risked their lives by working closely with Americans during the war and its aftermath, are trying to enter the U.S.
U.S. Secretary of State Antony Blinken met on Monday with Chinese President Xi Jinping and said they agreed to “stabilize” badly deteriorated U.S.-China ties, but America’s top diplomat left Beijing with his biggest ask rebuffed: better communications between their militaries.
